May 19, 2015 | The Israeli medical devices company Medigus filed a prospectus with the US Securities and Exchange Commission (SEC) to issue its shares as American depository receipts. Medigus currently has a market-cap of NIS 120 million ($31.1 million) and has planned for some time to trade their securities in the US. The largest shareholder in Medigus is OrbiMed Advisors. Medigus was founded in 2000 and develops innovative endoscopic devices.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments